Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines

Oncogene

Volumn 22, Issue 49, 2003, Pages 7781-7795

  DeArmond, Daniel ^a   Brattain, Michael G ^c   Jessup, John Milburn ^d   Kreisberg, Jeffrey ^a,b   Malik, Shazli ^a,b   Zhao, Shujie ^a   Freeman, James W ^a,b,e  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Cell signaling; ErbB 2; Growth factors; Pancreatic cancer

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GROWTH FACTOR; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; STAT3 PROTEIN; TYRPHOSTIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REDUCTION; REGULATORY MECHANISM;

CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; GROWTH SUBSTANCES; HUMANS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RETINOBLASTOMA PROTEIN; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

AGOUTI PACA;

EID: 0344873744     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206966     Document Type: Article

References (71)

1. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG. (1995). J. Biol. Chem., 270, 23589-23597.
2. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC and McGuire WL. (1992). Hum. Pathol., 23, 974-979.
3. Aziz N, Cherwinski H and McMahon M. (1999). Mol. Cell. Biol., 19, 1101-1115.
4. Bartkova J, Lukas J and Bartek J. (1997). Prog. Cell Cycle Res., 3, 211-220.
5. Basso AD, Solit DB, Munster, PN and Rosen N. (2002). Oncogene, 21, 1159-1166.
6. Bowman T, Garcia R, Turkson J and Jove R. (2000a). Oncogene, 19, 2474-2488.
7. Bowman T, Garcia R, Turkson J and Jove R. (2000b). Oncogene, 19, 2474-2488.
8. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA and Jove R. (2001). Proc. Natl. Acad. Sci. USA, 98, 7319-7324.
9. Brennan PJ, Kumogai T, Berezov A, Murali R and Greene MI. (2000). Oncogene, 19, 6093-6101.
10. Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reymaolds RK and Lin J. (2002). Oncogene, 20, 7925-7934.
11. Busse D, Doughty RS and Arteaga CL. (2000). Semin. Oncol., 27, 3-8, (discussion 92-100).
12. Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L and de Groot RP. (1996). J. Biol. Chem., 271, 13221-13227.
13. Catlett-Falcone R, Landowski T, Oshiro M, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton W and Jove R. (1999). Immunity, 10, 105-115.
14. Cheng M, Sexl V, Sherr CJ and Roussel MF. (1998). Proc. Natl. Acad. Sci. USA, 95, 1091-1096.
15. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM and Sherr CJ. (1999). EMBO J., 18, 1571-1583.
16. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y and Fu XY. (1996). Science, 272, 719-722.
17. Darnell Jr JE. (1997). Science, 277, 1630-1635.
18. Darnell Jr JE, Kerr IM and Stark GR. (1994). Science, 264, 1415-1421.
19. Diehl JA, Cheng M, Roussel MF and Sherr CJ. (1998). Genes De., 12, 3499-3511.
20. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA. (1987). Cell, 51, 1063-1070.
21. Di Marco E, Pierce JH, Knicley CL and Di Fiore PP. (1990). Mol. Cell. Biol., 10, 3247-3252.
22. Dugan MC, Dergham ST, Kucway R, Singh K, Biernat L, Du W, Vaitkevicius VK, Crissman JD and Sarkar FH. (1997). Pancreas, 14, 229-236.
23. Fernandes A, Hamburger AW and Gerwin BI. (1999). Int. J. Cancer, 83, 564-570.
24. Fralix KD, Ahmed MM, Mattingly C, Swiderski C, McGrath PC, Venkatasubbarao K, Kamada N, Mohiuddin M, Strodel WE and Freeman JW. (2000). Cancer, 88, 2010-2021.
25. Freeman JW, Mattingly CA and Strodel WE. (1995). J. Cell. Physiol., 65, 155-163.
26. Friess H, Wang L, Zhu Z, Gerber R, Schroder M, Fukuda A, Zimmermann A, Korc M and Buchler MW. (1999). Ann. Surg., 230, 767-774, discussion 774-775.
27. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R. (2001). Oncogene, 20, 2499-2513.
28. Gartel AL, Najmabadi F, Goufman E and Tyner AL. (2000). Oncogene, 19, 961-964.
29. Gjoerup O, Lukas J, Bartek J and Willumsen BM. (1998). J. Biol. Chem., 273, 18812-18818.
30. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ. (1998). J. Clin. Invest., 102, 1385-1392.
31. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ and Lemoine NR. (1990). J. Pathol. 161, 195-200.
32. Harari D and Yarden Y. (2000). Oncogene, 19, 6102-6114.
33. Howell GM, Humphrey LE, Awwad RA, Wang D, Koterba A, Periyasamy B, Yang J, Li W, Willson JK, Ziober BL, Coleman K, Carboni J, Lynch M and Brattain MG. (1998a). J. Biol. Chem., 273, 9214-9223.
34. Howell GM, Humphrey LE, Ziober BL, Awwad R, Periyasamy B, Koterba A, Li W, Willson JK, Coleman K, Carboni J, Lynch M and Brattain MG. (1998b). Mol. Cell. Biol., 18, 303-313.
35. Hung MC, Yan DH and Zhao XY. (1989). Proc. Natl. Acad. Sci. USA, 86, 2545-2548.
36. Hynes NE and Stern DF. (1994). Biochim. Biophys. Acta, 1198, 165-184.
37. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K and Silvennoinen O. (1995). Annu. Rev. Immunol., 13, 369-398.
38. Ihle JN. (1996). Cell, 84, 331-334.
39. Jaskiewicz K, Krige JE and Thomson J. (1994). Anticancer Res., 14, 1919-1922.
40. Jiang D, Yang H, Willson JK, Liang J, Humphrey LE, Zborowska E, Wang D, Foster J, Fan R and Brattain MG. (1998a). J. Biol. Chem., 273, 31471-31479.
41. Jiang D, Liang J, Humphrey LE, Yang H and Brattain MG. (1998b). J. Cell. Physiol., 175, 174-183.
42. Klapper LN, Kirschbaum MH, Sela M and Yarden Y. (2000). Adv. Cancer Res., 77, 25-79.
43. Kloppel G, Lingenthal G, von Bulow M and Kern HF. (1985). Histopathology, 9, 841-856.
44. Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M and Hirano T. (1999). J. Exp. Med., 189, 63-73.
45. Kokai Y, Myers JN, Wada T, Brown VI, LeVea CM, Davis JG, Dobashi K and Greene MI. (1989). Cell, 58, 287-292.
46. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchier M and Beger HG. (1992). J. Clin. Invest., 90, 1352-1360.
47. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E. (1997). Genes Dev., 11, 847-862.
48. Leaman DW, Leung S, Li X and Stark GR. (1996a). FASEB J., 10, 1578-1588.
49. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE and Stark GR. (1996b). Mol. Cell. Biol., 16, 369-375.
50. Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines III GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ and Pestell RG. (2000). Mol. Cell. Biol., 20, 672-683.
51. Levitzki A and Gazit A. (1995). Science, 267, 1782-1788.
52. Mack L, Kerkvliet N, Doig G and O'Malley FP. (1997). Hum. Pathol., 28, 974-979.
53. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi T, Azuma K, Tomita K, Komiyama S and Weinstein IB. (2002). Cancer Res., 62, 3351-3355.
54. Ohmichi M, Pang L, Ribon V, Gazit A, Levitzki A and Saltiel AR. (1993). Biochemistry, 32, 4650-4658.
55. Olayioye MA, Beuvink I, Horsch K, Daly JM and Hynes NE. (1999). J. Biol. Chem., 274, 17209-17218.
56. Osherov N, Gazit A, Gilon C and Levitzki A. (1993). J. Biol. Chem., 268, 11134-11142.
57. Satoh K, Sasano H, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Kobayashi N, Okano T, Toyota T and Sawai T. (1993). Cancer, 72, 51-56.
58. Schaefer LK, Ren Z, Fuller GN and Schafer TS. (2002). Oncogene, 21, 2058-2065.
59. Seidel HM, Milocco LH, Lamb P, Darnell Jr JE, Stein RB and Rosen J. (1995). Proc. Natl. Acad. Sci. USA, 92, 3041-3045.
60. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
61. Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ and Jove R. (2000). Oncogene, 19, 5419-5427.
62. Somerville JE, Clarke LA and Biggart JD. (1992). J. Clin. Pathol., 45, 16-20.
63. Sporn MB and Roberts AB. (1985). Nature, 313, 745-747.
64. Sporn MB and Todaro GJ. (1980). N. Engl. J. Med., 303, 878-880.
65. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS. (1995). Nat. Med., 1, 1257-1260.
66. Worsley SD, Ponder BA and Davies BR. (1997). Gynecol. Oncol., 64, 189-195.
67. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
68. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Kunz J, Beger HG and Korc M. (1993). Hum. Pathol., 24, 1127-1134.
69. Yeh TC and Pellegrini S. (1999). Cell. Mol. Life Sci., 55, 1523-1534.
70. Zhang H, Hannon GJ and Beach D. (1994). Genes Dev., 8, 1750-1758.
71. Ziober BL, Willson JK, Hymphrey LE, Childress-Fields K and Brattain MG. (1993). J. Biol. Chem., 268, 691-698.